Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention

NCT00404781 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

305

Enrollment

OTHER

Sponsor class

Conditions

Ischemic Heart Disease
Acute Coronary Syndromes

Interventions

DRUG: cilostazol in addition to aspirin and clopidogrel

Sponsor

Shenyang Northern Hospital